Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

SIMPLE SUMMARY: The mainstay of therapy for primary advanced ovarian, fallopian tube, and primary peritoneal carcinoma is cytoreductive surgery (CRS) and platinum-containing chemotherapy. Since the primary and recurrent disease is mainly confined to the peritoneal cavity, intraperitoneal chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Acs, Miklos, Herold, Zoltan, Szasz, Attila Marcell, Mayr, Max, Häusler, Sebastian, Piso, Pompiliu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315737/
https://www.ncbi.nlm.nih.gov/pubmed/35884361
http://dx.doi.org/10.3390/cancers14143301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315737/
https://www.ncbi.nlm.nih.gov/pubmed/35884361
http://dx.doi.org/10.3390/cancers14143301

Ejemplares similares